A new study shows that the risk of developing dementia anytime after age 55 among Americans is 42%, more than double the risk reported by older studies.
Telix plans $125m acquisition of radiopharmaceuticals company QSAM – Pharmaceutical Technology
Share this article If the QSAM acquisition is terminated, the option fee and upfront costs will be converted to QSAM common stock, priced at $6.70